Stockle - the stock oracle

Apotheca Biosciences, Inc.

US:PCFPUS:CBDC
No current share price held for this company.

Past year: ▼ 98%(0.01c – 7.00c USD)

Market cap
—
Shares on issue
—
Story beats
16 since 2017
Last event
27 June 2019

History

A Nevada mining shell that never mined chased cannabis licences, took over by a Florida CBD business in 2018, announced three deals in 2019, then stopped filing.

2014-2017: A mining shell looks for a business

The company began as Pacificorp Holdings, Ltd., incorporated in Nevada in October 2014 to develop and explore mineral properties. It never mined. It registered with the SEC in 2015, filed quarterly reports and little else, and its share count stayed at 8,390,000 through 2016.

In March 2017 it signed a letter of intent to license Affordable Green Washington's marijuana products and marketing model for Washington State, for $2.1 million in stages. A definitive exclusive licence followed in May, and director Wan Soo Lee resigned the same day. The fee was then raised to $2.2 million on 1 June and to $2.3 million by an addendum dated 25 July, with the schedule running to 26 October 2017 and 100,000 restricted shares promised to the licensor on closing. Only about $70,000 was ever paid.

In June the company renamed itself Cannabis Leaf Incorporated through a merger with a shell subsidiary, which needed no shareholder vote, and split its shares six-for-one. In August chief executive Jason Sakowski bought 27 million restricted shares from the former directors and officers for a combined $15,000, with payment deferred to March 2018. In October the company signed a second letter of intent, to take over Green Venture Capital's deal with licensed grower MMS Farms for $500,000. The auditor, TAAD, LLP, was dismissed in December after two going-concern opinions.

2018: The Apotheca takeover

In March 2018 the company agreed to issue 60 million new shares, about 60% of the enlarged company, to the owners of a private Florida business called Apotheca Biosciences. That business took the board, the officers and the name. The deal had in fact closed on 6 March. Year-end shares on issue rose to 114,398,250 after a year-end figure of 50,340,000 in 2017.

In May both Washington deals were abandoned. The Affordable Green licence was settled and cancelled for 2.6 million restricted shares, and the MMS Farms letter of intent was terminated with nothing paid.

The full takeover disclosure was not filed until 30 August, about six months after closing. It showed a company based in St Petersburg, Florida, with no revenue and a going-concern problem. Its cash had come from small related-party loans, and chairman Sam Talari held about 68% of the votes.

In November the company sued in a Florida state court for a declaration that it had never been a shell company, after a broker's lawyer told shareholders it had been, which would block resales under Rule 144. On 14 December the court issued the order, freeing shareholders to sell.

2019: Three announcements, then silence

In June 2019 the company announced three deals within four weeks. On 5 June it said it had agreed to come to a definitive agreement to buy 51% of Hemp Sciences Corp for 60 million shares valued at six cents each. The target was a division of Nuvus Corp, one of the related parties that had lent the company cash. On 21 June came a similar agreement for 51% of Hemp Bloom LLC and its 600 acres in Colorado and Oregon, with projected revenue of $38 million to $182 million by 2020. On 27 June it took an exclusive licence to sell CB Scientific's Test4 cannabis test kits under its ProMED brand, paying a 30-40% royalty on each kit.

None of the first two deals was ever completed or mentioned again. The last annual report was filed in May 2019 and the last filing of any kind, an officer change, was on 9 August 2019. The SEC revoked the company's registration on 1 September 2021. It was not bankrupt and had not been acquired.

Written from the 16 story beats below (2017 to 27 June 2019), which come from the company's own announcements and filings.

Beat by beat

The events that changed the company's story, in plain English, each written against everything known about the company at the time. The dot shows whether it was good, bad or neutral for shareholders.

shares on issue market cap (log scale)

2019119m shares · US$7.2m market cap

  1. 27 June

    Took an exclusive licence to sell CB Scientific's Test4 cannabis test kits under its ProMED brand, paying a 30-40% royalty on every kit. The third deal announced in a month, and the only one with an actual product attached; six weeks later the company stopped filing altogether.

    material agreement

    119m shUS$7.2m
  2. 21 June

    Two weeks later, a second agreement-to-agree: 51% of Hemp Bloom LLC and its 600 acres in Colorado and Oregon, with the filing projecting $38 million of CBD or $182 million of CBG revenue by 2020 while conceding it might not be able to farm the land at all. Nothing further was ever filed about it.

    material agreement

    119m shUS$7.2m
  3. 5 June

    Announced it had "agreed to come to a definitive agreement" to buy 51% of Hemp Sciences Corp for 60 million shares valued at six cents each, doubling the share count for a business that is a division of Nuvus Corp - one of the related parties that had been lending the company its operating cash. No definitive agreement or completion was ever filed.

    material agreement

    119m shUS$7.2m

2018114m shares · US$59.2m market cap

  1. 14 Dec

    The Florida circuit court gave the company what it asked for: an order finding it was not and never had been a shell company, freeing shareholders to sell under Rule 144. The company's own history - incorporated to explore minerals, never mining, then licensing, then a reverse takeover - is exactly the shape the shell definition exists to catch.

    other material event

    114m shUS$59.2m
  2. 29 Nov

    Sued in a Florida state court for a declaration that it had never been a "shell" company, after a broker's lawyer told shareholders it had been - which would block them from selling under Rule 144. A company asking a county court to settle a federal securities-law question about its own past.

    other material event

    114m shUS$50.1m
  3. 31 Aug

    Filed the full disclosure record for the Apotheca takeover, which had actually closed on 6 March 2018 and been announced by press release in June - roughly six months before this filing. The company moved to St Petersburg, Florida, said it had no revenue and a going-concern problem, and disclosed that its cash had come from small related-party loans; chairman Sam Talari is described as holding about 68% of the votes.

    business combination

    51.3m shUS$28.2m
  4. 7 May

    Walked away from both Washington deals at once: the Affordable Green licence was settled and cancelled for 2.6 million restricted shares, and the Green Venture / MMS Farms letter of intent was terminated with nothing ever paid. Fourteen months and a string of small payments produced no business, and the shares came out of shareholders' pockets.

    material agreement termination

    60.0m shUS$49.2m
  5. 9 Mar

    Agreed to issue 60 million shares for all of Apotheca Biosciences, a Nevada corporation, which would take control of the board and officers and rename the company. Closing was projected for the end of March 2018.

    business combination

    50.3m shUS$19.1m

201750.3m shares · US$44.0m market cap

  1. 2 Nov

    Signed a second letter of intent, this time to take over Green Venture Capital's own letter of intent with MMS Farms, a licensed Washington marijuana grower, for $500,000 payable in instalments. A deal to buy a right to a deal - and still four months behind on the first licence it signed.

    material agreement

    50.3m shUS$44.0m
  2. 7 Aug

    Chief executive Jason Sakowski bought 27 million restricted shares from the company's former directors and officers for a combined $15,000, taking control outright. Control of a listed company changed hands for the price of a used car, with payment not due until March 2018.

    material agreement

    50.3m shUS$53.9m
  3. 1 Aug

    On 25 July 2017 the company, now named Cannabis Leaf, Inc., signed an addendum to its Affordable Green Washington licence, raising the total fee again to $2,300,000 with a new schedule running to 26 October 2017. Of that, only the first four payments totalling $60,000 are marked paid; the licensor also gets 100,000 restricted shares on closing, and another 100,000 if a payment is more than 15 days late after 25 August 2017. The filing also records a move of the company's address to 4500 9th Avenue NE, Seattle. This continues the licence deal, with the fee and payment dates changed a second time.

    material agreement

    50.3m shUS$53.9m
  4. 31 July

    Rewrote the Affordable Green licence again, raising the total to $2.3 million with a new schedule to 26 October 2017. Only $60,000 in four payments was marked paid, and the licensor was also to receive 100,000 restricted shares.

    material agreement

    50.3m shUS$53.9m
  5. 22 June

    Renamed itself Cannabis Leaf Incorporated by merging a shell subsidiary of that name into itself - a paperwork device that needed no shareholder vote - and at the same time multiplied its shares six-for-one and raised its authorised capital. The mineral-exploration identity was formally dropped for a cannabis one.

    bylaws amendment

    8.4m sh
  6. 6 June

    On 1 June 2017 the company (still named Pacificorp Holdings) amended its Washington State licence with Affordable Green Washington LLC, raising the total fee to $2,200,000 and replacing the earlier schedule with a new one. Payments of $25,000, $9,800 were acknowledged as received, with $15,200 and $10,000 due in early June and the rest in stages from $75,000 on 30 June up to a final $815,000 on 30 October 2017. This continues the May licence deal on a larger and more spread-out payment plan.

    material agreement

    8.4m sh
  7. 9 May

    Converted the March letter of intent into a definitive exclusive licence with Affordable Green Washington, due $25,000 on signing, $100,000 by end of May and $2 million by 30 September 2017. Director Wan Soo Lee resigned the same day.

    material agreement

    8.4m sh
  8. 4 Apr

    Pacificorp Holdings - a Nevada shell incorporated in 2014 to explore mineral properties, with no mining ever done - signed a letter of intent to license Affordable Green Washington's marijuana products and marketing model for Washington State, promising $2.1 million in stages. The first move in a three-year hunt for a business to be in.

    material agreement

    50.3m sh